BMAL1 and neurodegenerative disease: Because motor phenotypes resemble symptoms observed in neurodegenerative diseases like Parkinson’s and Huntington’s disease (Carter et al., 1999; Sedelis et al., 2001), we tested whether dopamine signaling was affected by the conditional Bmal1 knockout.